8-K current report · filed Feb 26, 2026

NOVAVAX INC (NVAX) 8-K Current Report: February 26, 2026

Item 2.02NVAX overview

Short answer

NOVAVAX INC (NVAX) filed an 8-K current report with the SEC on February 26, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q4 2025 earnings release issued Feb 26, 2026: covers quarter ended Dec 31, 2025.

NOVAVAX INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q4 2025 earnings release issued Feb 26, 2026: covers quarter ended Dec 31, 2025
  • Full financial details in Exhibit 99.1 of this 8-K filing

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other NOVAVAX INC 8-K filings

Get the next NVAX 8-K as it lands

Follow NVAX for push alerts, or ask the research agent what this filing means.